Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C David Mazer

Showing results (211-220 of 282) with videos related to

Pageof 29
Sort By:
European Heart Journal|August 31, 2025
Semaglutide promotes bone marrow-derived progenitor cell flux toward an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trialBrady Park, Fallon Dennis, Arianna Z He, et al.
Metabolism Open|August 20, 2020
Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysisVinay Garg, Subodh Verma, Kim A Connelly, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 11, 2020
Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red lightKyle Chin, Melina P Cazorla-Bak, Elaine Liu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 29, 2023
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodelingEhab Bakbak, Subodh Verma, Aishwarya Krishnaraj, et al.
European Journal of Preventive Cardiology|March 31, 2026
Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 StudyMichael Szarek, Lawrence A Leiter, Hwee Teoh, et al.
The New England Journal of Medicine|February 21, 2003
One-year outcomes in survivors of the acute respiratory distress syndromeMargaret S Herridge, Angela M Cheung, Catherine M Tansey, et al.
Intensive Care Medicine Experimental|December 8, 2023
Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trialQuirin Notz, Daren K Heyland, Zheng-Yii Lee, et al.
The Annals of Thoracic Surgery|September 30, 2023
Association of Cerebral Oximetry With Brain Ischemic Lesions and Functional Outcomes in Arch RepairMakoto Hibino, Mark D Peterson, Ricardo Tachibana, et al.
BMJ Open|June 22, 2022
Functional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major surgery in older adultsDuminda N Wijeysundera, Shabbir M H Alibhai, Karim S Ladha, et al.
Cardiovascular Endocrinology & Metabolism|June 29, 2026
Proteomics analysis of empagliflozin in patients without diabetes or overt heart failure from empagliflozin and cardiac remodeling in people without diabetes CardioLink-7 randomized clinical trialWei-Siang Chen, Ning-I Yang, Subodh Verma, et al.
Pageof 29

Showing results (211-220 of 282) with videos related to

Sort By:
Pageof 29
European Heart Journal|August 31, 2025
Semaglutide promotes bone marrow-derived progenitor cell flux toward an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trialBrady Park, Fallon Dennis, Arianna Z He, et al.
Metabolism Open|August 20, 2020
Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysisVinay Garg, Subodh Verma, Kim A Connelly, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 11, 2020
Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red lightKyle Chin, Melina P Cazorla-Bak, Elaine Liu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 29, 2023
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodelingEhab Bakbak, Subodh Verma, Aishwarya Krishnaraj, et al.
European Journal of Preventive Cardiology|March 31, 2026
Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 StudyMichael Szarek, Lawrence A Leiter, Hwee Teoh, et al.
The New England Journal of Medicine|February 21, 2003
One-year outcomes in survivors of the acute respiratory distress syndromeMargaret S Herridge, Angela M Cheung, Catherine M Tansey, et al.
Intensive Care Medicine Experimental|December 8, 2023
Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trialQuirin Notz, Daren K Heyland, Zheng-Yii Lee, et al.
The Annals of Thoracic Surgery|September 30, 2023
Association of Cerebral Oximetry With Brain Ischemic Lesions and Functional Outcomes in Arch RepairMakoto Hibino, Mark D Peterson, Ricardo Tachibana, et al.
BMJ Open|June 22, 2022
Functional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major surgery in older adultsDuminda N Wijeysundera, Shabbir M H Alibhai, Karim S Ladha, et al.
Cardiovascular Endocrinology & Metabolism|June 29, 2026
Proteomics analysis of empagliflozin in patients without diabetes or overt heart failure from empagliflozin and cardiac remodeling in people without diabetes CardioLink-7 randomized clinical trialWei-Siang Chen, Ning-I Yang, Subodh Verma, et al.
Pageof 29